ImmunityBio (IBRX) P/E (2017 - 2026)
ImmunityBio (IBRX) P/E from Jan 3, 2017 to Jul 21, 2026. The TTM ImmunityBio (IBRX) P/E is -9.67. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of ImmunityBio (IBRX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -9.67 | +86.74% |
| 2025 | -5.18 | -0.57% |
| 2024 | -5.21 | -16.01% |
| 2023 | -6.20 | +0.40% |
| 2022 | -6.17 | -26.35% |
| 2021 | -8.38 | +0.79% |
| 2020 | -8.32 | +251.67% |
| 2019 | -2.37 | +123.71% |
| 2018 | -1.06 | -81.50% |
| 2017 | -5.72 | N/A |
Comparison ImmunityBio (IBRX) P/E with competitors
ImmunityBio (IBRX) P/E is -9.67.